Please utilize analysis of Desh Rakshak Aushdha fundamentals to determine if markets are correctly pricing the company. We found twenty-six available fundamental indicators for Desh Rakshak Aushdhalaya Limited which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Desh Rakshak Aushdha fundamentals including its Net Income as well as the relationship between Current Ratio and Beta . Use Desh Rakshak to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Desh Rakshak to be traded at 4.74 in 30 days.
Desh Rakshak Company Summary
Desh Rakshak competes with Sun Pharmaceutical, Aurobindo Pharma, Dr Reddys, Divis Laboratories, and Lupin. Desh Rakshak Aushdhalaya Limited manufactures and sells ayurvedic and herbal products in India. Desh Rakshak Aushdhalaya Limited was founded in 1901 and is headquartered in Haridwar, India. Desh Rakshak operates under Drug Manufacturers - Specialty Generic classification in India and is traded on Bombay Stock Exchange.
Desh Rakshak Aushdhalaya Limited is rated below average in gross profit category among related companies. It is rated below average in number of employees category among related companies . The ratio of Gross Profit to Number of Employees for Desh Rakshak Aushdhalaya Limited is about 13,035,000
Desh Rakshak Market Fundamentals
Desh Rakshak Financial Distress Probability
Chance of Financial Distress
Desh Rakshak Aushdhalaya Limited has less than 47 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info